MDR1 single nucleotide polymorphisms: multiplicity of haplotypes and functional consequences
- 1 August 2002
- journal article
- editorial
- Published by Wolters Kluwer Health in Pharmacogenetics
- Vol. 12 (6) , 425-427
- https://doi.org/10.1097/00008571-200208000-00002
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Distinct haplotype profiles and strong linkage disequilibrium at the MDR1 multidrug transporter gene locus in three ethnic Asian populationsPharmacogenetics, 2002
- C3435T polymorphism in the MDR1 gene affects the enterocyte expression level of CYP3A4 rather than Pgp in recipients of living-donor liver transplantationPharmacogenetics, 2002
- C3435T Mutation in Exon 26 of the Human MDR1 Gene and Cyclosporine Pharmacokinetics in Healthy SubjectsTherapeutic Drug Monitoring, 2002
- MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadineBritish Journal of Clinical Pharmacology, 2002
- Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyThe Lancet, 2002
- Drugs as P-glycoprotein substrates, inhibitors, and inducersDrug Metabolism Reviews, 2002
- Identification of functionally variant MDR1 alleles among European Americans and African AmericansClinical Pharmacology & Therapeutics, 2001
- MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.Pharmaceutical Research, 2001
- Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivoProceedings of the National Academy of Sciences, 2000
- P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs.Journal of Clinical Investigation, 1996